Immuno-oncology | Australian Biotech Company News

Home Tags Immuno-oncology

Biotechnology

Engineered Probiotic Bacteria Deliver Anticancer Nanobodies to Regress Tumors in Mice

BioChannel - February 13, 2020

Biotechnology

This Cancer Immunotherapy Attacks the Sugar Coat of Tumor Cells

BioChannel - January 31, 2020

Biotechnology

OncoCyte Launches NSCLC Stratification Test, Looks beyond Lung Cancer

BioChannel - January 24, 2020

Biotechnology

“Skeleton Key” T-Cell Receptor Works across Multiple Cancer Types

BioChannel - January 23, 2020

Biotechnology

Astellas Acquires Xyphos for Up to $665M, Boosting Cancer Immunotherapy Pipeline

BioChannel - December 27, 2019

Biotechnology

Merck & Co., Sanofi Shell Out $5.2B in Deals to Strengthen...

BioChannel - December 9, 2019

Biotechnology

German Cancer Virotherapy Biotech Launches with €12M Series A

BioChannel - October 15, 2019

Biotechnology

Tocagen Axing 65% of Staff after Cancer Immunotherapy Combination Fails Phase...

BioChannel - October 4, 2019

Biotechnology

RNA Therapies, Immunotherapies and Cancer Tests Showcased in Spain

BioChannel - October 2, 2019

Biotechnology

Breathalyzer Sniffs Out Potential Cancer Immunotherapy Responders

BioChannel - September 18, 2019

12 Page 1 of 2

Stay connected

Recent posts

Scientists receive CPRIT grants for lung, kidney cancer research

BioChannel - February 21, 2020

A genetic map for maize

BioChannel - February 21, 2020

At Laboratory for Advanced Medicine, New CEO Sharpens Commercial Focus

BioChannel - February 21, 2020

Random article

Scientists receive CPRIT grants for lung, kidney cancer research

A genetic map for maize

At Laboratory for Advanced Medicine, New CEO Sharpens Commercial Focus

Optogenetic Modulation for the Treatment of Traumatic Brain Injury